Archive for January, 2009

Business Wire - Schaeffer’s Early Edge: eBay, Eli Lilly, and Yahoo!

Friday, January 9th, 2009

CINCINNATI — Eli Lilly (NYSE: LLY) announced this morning that it has withdrawn its supplemental new drug application for Cymbalta from the U.S. Food and Drug Administration (FDA). LLY’s Cymbalta is used for the management of chronic pain. LLY noted that it intends to resubmit the application in the first half of …

PR Newswire Europe - U.S. Regulators Approve Cymbalta(R) for Treatment of Generalised Anxiety Disorder.

Sunday, January 4th, 2009

INDIANAPOLIS, February 26 /PRNewswire/ —
The U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta(R) (duloxetine HCl) for the treatment of generalised anxiety disorder (GAD), Eli Lilly and Company (NYSE: LLY) and Boehring…